Renovaro Inc. - Common Stock (NQ: RENB )
0.4950
+0.0150
(+3.13%)
Streaming Delayed Price
Updated: 1:51 PM EDT, Sep 27, 2024
Add to My Watchlist
Press Releases about Renovaro Inc. - Common Stock
Patients with Swelling Disorder See New Gene Therapy as Godsend
February 07, 2024
Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
January 16, 2024
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Study Shows Ongoing Benefits Once Immunotherapy Stops
January 02, 2024
Researchers Harnessing Immune System to Fight Cancer More Effectively
December 07, 2023
Study Says Patients on Gene Therapy Need Long-Term Monitoring
November 27, 2023
Unlocking AI investment opportunities in healthcare
November 16, 2023
Via MarketBeat
Exposures
Artificial Intelligence
How Immunotherapy Is Cementing a Role in Cancer Treatment
November 13, 2023
Alarming Data Highlights Gaps in Treating People with Chronic HBV
November 01, 2023
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.